NARAYANA HRUDAYALAYA LTD.

Operates a multi-specialty hospital chain providing inpatient and outpatient care across India, the Cayman Islands and the UK, with the India network forming the core business. The medical and healthcare related services segment accounted for 94.1% of FY26 revenue at Rs 7,688.687 crore, alongside smaller 'Others' (4.7%) and unallocated (1.2%) streams. India runs high-end procedures such as robotic cardiac surgery and bone marrow transplants concentrated in the Bangalore cluster, while the Cayman operation includes an insurance book and the recently acquired UK business, Practice Plus, runs hospitals that are 90% NHS-funded. Employee costs are the largest disclosed expense at 22.8% of revenue, other operating expenses at 37.5% and depreciation at 5.7%. A capex pipeline of 6 projects is planned to add 1,535 beds by FY30, funded via internal accruals and debt under a cumulative capex envelope of approximately Rs 3,000 crore.